Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer

Cancer Science

Volumn 105, Issue 7, 2014, Pages 802-811

  Nishikawa, Rika ^a,b   Goto, Yusuke ^a,b   Sakamoto, Shinichi ^b   Chiyomaru, Takeshi ^c   Enokida, Hideki ^c   Kojima, Satoko ^d   Kinoshita, Takashi ^a   Yamamoto, Noriko ^a   Nakagawa, Masayuki ^c   Naya, Yukio ^d   Ichikawa, Tomohiko ^b   Seki, Naohiko ^a  

^a Department of Functional Genomics ^*  (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

LASP1; MicroRNA; miR 218; Prostate cancer; Tumor suppressor

Indexed keywords

MICRORNA; MICRORNA 218; PROTEIN LASP1; PROTEIN SH3; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN TARGETING; TUMOR INVASION; UPREGULATION;

LASP1; MICRORNA; MIR-218; PROSTATE CANCER; TUMOR SUPPRESSOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM DOMAIN PROTEINS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84904288804     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12441     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Bott SR, Birtle AJ, Taylor CJ, Kirby RS. Prostate cancer management: 2. An update on locally advanced and metastatic disease. Postgrad Med J 2003; 79: 643-5.
3. Timsit MO, Lebret T, Mejean A. Chemotherapy of hormonorefractory and hormonoresistant metastatic prostate cancer. Prog Urol 2008; 18(Suppl 7): S365-75.
4. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-55.
5. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
6. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet 2008; 9: 102-14.
7. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
8. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008; 319: 1785-6.
9. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-56.
10. Fuse M, Kojima S, Enokida H et al. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. J Hum Genet 2012; 57: 691-9.
11. Kojima S, Chiyomaru T, Kawakami K et al. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 2012; 106: 405-13.
12. Kojima S, Enokida H, Yoshino H et al. The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. J Hum Genet 2013;. doi:10.1038/jhg.2013.121.
13. Chiyomaru T, Enokida H, Tatarano S et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer 2010; 102: 883-91.
14. Yoshino H, Chiyomaru T, Enokida H et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011; 104: 808-18.
15. Nohata N, Hanazawa T, Kikkawa N et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer 2011; 105: 833-41.
16. Chiyomaru T, Enokida H, Kawakami K et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol 2012; 30: 434-43.
17. Yamasaki T, Seki N, Yoshino H et al. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol 2013; 190: 1059-68.
18. Yamamoto N, Kinoshita T, Nohata N et al. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma. Int J Oncol 2013; 42: 1523-32.
19. Kinoshita T, Hanazawa T, Nohata N et al. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 2012; 3: 1386-400.
20. Alajez NM, Lenarduzzi M, Ito E et al. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011; 71: 2381-91.
21. Wu DW, Cheng YW, Wang J, Chen CY, Lee H. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 2010; 70: 10392-401.
22. Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41-9.
23. Song L, Huang Q, Chen K et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-beta. Biochem Biophys Res Commun 2010; 402: 135-40.
24. Uesugi A, Kozaki K, Tsuruta T et al. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011; 71: 5765-78.
25. Tie J, Pan Y, Zhao L et al. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6: e1000879.
26. Tomasetto C, Moog-Lutz C, Regnier CH, Schreiber V, Basset P, Rio MC. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett 1995; 373: 245-9.
27. Tomasetto C, Regnier C, Moog-Lutz C et al. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 1995; 28: 367-76.
28. Keicher C, Gambaryan S, Schulze E, Marcus K, Meyer HE, Butt E. Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. Biochem Biophys Res Commun 2004; 324: 308-16.
29. Rachlin AS, Otey CA. Identification of palladin isoforms and characterization of an isoform-specific interaction between Lasp-1 and palladin. J Cell Sci 2006; 119: 995-1004.
30. Li B, Zhuang L, Trueb B. Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J Biol Chem 2004; 279: 20401-10.
31. Mori M, Nakagami H, Koibuchi N et al. Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol Biol Cell 2009; 20: 3115-24.
32. Mise N, Savai R, Yu H, Schwarz J, Kaminski N, Eickelberg O. Zyxin is a transforming growth factor-beta (TGF-beta)/Smad3 target gene that regulates lung cancer cell motility via integrin alpha5beta1. J Biol Chem 2012; 287: 31393-405.
33. Grunewald TG, Kammerer U, Schulze E et al. Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp Cell Res 2006; 312: 974-82.
34. Grunewald TG, Kammerer U, Winkler C et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 2007; 96: 296-305.
35. Wang C, Zheng X, Shen C, Shi Y. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res 2013; 31: 58.
36. He B, Yin B, Wang B et al. Overexpression of LASP1 is associated with proliferation, migration and invasion in esophageal squamous cell carcinoma. Oncol Rep 2013; 29: 1115-23.
37. Takeshita N, Mori M, Kano M et al. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1. Int J Oncol 2012; 41: 1653-61.